General Announcement::Press Release - Grant from SIIRD to Begin Clinical Trial in Stress Urinary Incontinence Patients
Issuer & Securities
Issuer/ Manager
THE TRENDLINES GROUP LTD.
Securities
THE TRENDLINES GROUP LTD. - IL0011328858 - 42T
Stapled Security
No
Announcement Details
Announcement Title
General Announcement
Date &Time of Broadcast
29-Mar-2017 07:06:55
Status
New
Announcement Sub Title
Press Release - Grant from SIIRD to Begin Clinical Trial in Stress Urinary Incontinence Patients
Announcement Reference
SG170329OTHRA8N6
Submitted By (Co./ Ind. Name)
Yosef Ron
Designation
Joint Company Secretary
Description (Please provide a detailed description of the event in the box below)
Trendlines Receives Grant from SIIRD to Begin Clinical Trial in Stress Urinary Incontinence Patients
- Please see attached.
Attachments
Press Release - Labs_SIIRD_SGH FINAL.pdf
Total size =104K
Related Announcements
Related Announcements